C4X Discovery
Pre-clinicalC4X Discovery uses computational chemistry and AI to design small molecule drugs for addiction, inflammatory diseases, and neurodegeneration.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $32.8M
About
C4X Discovery uses computational chemistry and AI to design small molecule drugs for addiction, inflammatory diseases, and neurodegeneration.
Small Molecules
Funding History
3Total raised:$32.8M
Debt$5MNov 15, 2020
Grant$2.8MMay 15, 2018
IPO$25MDec 15, 2014